文献速递白内障与屈光手术

开发患者报告结局量表评估白内障手术与人工晶状体植入相关症状

Development of a Patient-Reported Outcome Measure to Assess Symptoms Associated with Cataract Surgery and Intraocular Lens Implants.
PubMed 文献 · Ophthalmology · 2023-04-12

该观察性研究在术前(n=716)和术后(n=554)对计划双眼植入同类型人工晶状体的成人进行网络问卷调查,评估14种视觉症状的频率、严重程度和困扰程度,并检验37条目AIOLIS量表的性能。术后多数症状的困扰比例显著下降(P<0.0001),但暗新月形阴影无显著变化;单焦点晶状体植入与光晕、星芒、眩光等减少更多相关,但自报总体视力改善较少。

要点

  • 术后眩光、视物模糊、星芒、雾视、雪球、光晕的困扰比例均显著下降(P<0.0001)。
  • 暗新月形阴影的困扰比例术前4% vs 术后4%,无显著变化。
  • 单焦点晶状体植入与光晕、星芒、眩光、环状及蜘蛛网状物减少更多相关,但自报总体视力改善较少。

核心结论

  • 本研究为37条目的人工晶状体植入症状评估量表(AIOLIS)提供了支持,可用于临床研究和临床诊疗中评估症状及总体视力感知。

研究设计与样本

  • 观察性研究,在人工晶状体植入前后评估量表和症状体验。
  • 参与者为计划双眼植入同类型人工晶状体的成人,术前基线完成调查n=716,术后完成调查n=554。
  • 调查通过网页问卷进行,辅以邮件随访和电话提醒。
  • 主要结局指标为14种症状(眩光、雾视、视物模糊、星芒、光晕、雪球、飞蚊、双影、环状及蜘蛛网状物、变形、闭眼闪光、睁眼闪光、闪烁图像、暗影)在过去7天内的频率、严重程度和困扰程度。

主要发现

  • 术前14种症状之间相关性的中位数仅为0.19。
  • 平均未矫正双眼视力从术前0.47 logMAR(Snellen 20/59)改善至术后0.12(20/26),最佳矫正双眼视力从术前0.23 logMAR(20/34)改善至术后0.05 logMAR(20/22)。
  • 术后最困扰症状的比例较术前下降:眩光84%/36%、视物模糊68%/22%、星芒66%/28%、雾视63%/18%、雪球55%/17%、光晕52%/22%。
  • 除暗新月形阴影(4%/4%)外,所有症状从术前到术后均显著减少(P<0.0001)。
  • 除暗新月形阴影(29%/32%)外,评为相当或极度困扰的症状比例从术前到术后下降:视物模糊54%/15%、雪球52%/14%、眩光49%/15%、光晕46%/14%。

关键数值与推荐

  • 37条目的人工晶状体植入症状评估量表(AIOLIS)获本研究支持,用于临床研究和临床诊疗中评估症状及总体视力感知。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To develop a standardized patient-reported outcome measure of visual perceptions and symptoms for implanted premium and monofocal intraocular lenses (IOLs). DESIGN: Observational study before and after IOL implants to assess the measure and symptom experience. PARTICIPANTS: Adults scheduled for binocular implantation of the same IOL type completed the survey at baseline prior to surgery (n = 716) and postoperatively (n = 554). Most respondents were female (64%), White (81%), 61 or older (89%), and had some college or more education (62%). METHODS: Administration was by web survey with mail follow-up and phone reminders. MAIN OUTCOME MEASURES: Frequency, severity, and level of symptom bother in the last 7 days for 14 symptoms: (1) glare, (2) hazy vision, (3) blurry vision, (4) starbursts, (5) halos, (6) snowballs, (7) floaters, (8) double images, (9) rings and spider webs, (10) distortion, (11) light flashes with eyes closed, (12) light flashes with eyes open, (13) shimmering images, and (14) dark shadows. RESULTS: The median correlation among having 14 symptoms at baseline was only 0.19. Mean uncorrected binocular visual acuity improved from a preoperative value of 0.47 logarithm of the minimum angle of resolution (logMAR; Snellen 20/59) to a postoperative value of 0.12 (20/26) and best-corrected binocular visual acuity improved from 0.23 logMAR (20/34) preoperative to 0.05 logMAR (20/22) postoperative. The most bothersome symptoms were reduced after surgery: preoperative/postoperative glare (84%/36%), blurry vision (68%/22%), starbursts (66%/28%), hazy vision (63%/18%), snowballs (55%/17%), and halos (52%/22%). All symptoms decreased significantly (P < 0.0001) from before to after surgery except for dark crescent-shaped shadows (4%/4%). The percentage of symptoms rated as quite a bit or extremely bothersome declined from before to after surgery except for dark crescent-shaped shadows (29%/32%): blurry vision (54%/15%), snowballs (52%/14%), glare (49%/15%), and halos (46%/14%). Having monofocal IOL implants was associated with significantly more reduction in halos, starbursts, glare, and rings and spider webs, but less improvement in self-reported general vision. CONCLUSIONS: This study provides support for the 37-item Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) instrument for use to assess symptoms and general perceptions of vision in clinical studies and clinical care. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Hays RD, MacRae S, Holladay J, et al. Development of a Patient-Reported Outcome Measure to Assess Symptoms Associated with Cataract Surgery and Intraocular Lens Implants. Ophthalmology. 2023. PMID: 37055289. doi:10.1016/j.ophtha.2023.02.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。